Stay updated on Senolytic Therapy in Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Senolytic Therapy in Alzheimer's Clinical Trial page.

Latest updates to the Senolytic Therapy in Alzheimer's Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check41 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check55 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check62 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference0.2%
- Check84 days agoChange DetectedWashington University School of Medicine has been added with an estimated last update posted on December 18, 2024, while the entry for Principal Investigator Suzanne Craft, PhD from Wake Forest University Health Sciences has been removed.SummaryDifference1%
Stay in the know with updates to Senolytic Therapy in Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Senolytic Therapy in Alzheimer's Clinical Trial page.